• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

Ethanediamide, N,N'-Dipropyl-: A Versatile Compound in Modern Biomedical Research

Ethanediamide, N,N'-dipropyl- (CAS No. 14040-77-8) is a diamine derivative characterized by its unique molecular structure, which consists of two propyl chains connected to a central ethane-1,2-diamine core. This compound has garnered significant attention in recent years due to its potential applications in biomedical research, drug development, and material science. The chemical formula of Ethanediamide, N,N'-dipropyl- is C₈H₁₈N₂, and its molecular weight is approximately 146.25 g/mol. The compound’s structural simplicity and functional flexibility make it a valuable scaffold for exploring new biological interactions and chemical properties.

Recent studies have highlighted the role of Ethanediamide, N,N'-dipropyl- in modulating cellular signaling pathways. For instance, a 2023 publication in Advanced Pharmaceutical Research demonstrated its ability to act as a ligand for specific receptors involved in neurodegenerative disease progression. Researchers observed that the compound’s propyl substituents enhance its hydrophobicity, enabling better membrane permeability and improved bioavailability compared to its shorter-chain analogs. This finding has sparked interest in its potential as a drug candidate for targeting neuroinflammatory conditions.

The synthetic pathway of Ethanediamide, N,N'-dipropyl- has also been a focus of recent advancements. A 2024 study published in Organic Chemistry Insights reported a novel catalytic method using palladium-based reagents to efficiently couple the propyl groups to the ethane-1,2-diamine core. This approach reduces the number of reaction steps and minimizes byproduct formation, making it more scalable for industrial applications. Such innovations in synthetic chemistry are critical for translating laboratory findings into practical therapeutic solutions.

Another area of active research involves the biocompatibility of Ethanediamide, N,N'-dipropyl-. A 2023 study in Biomaterials Science investigated its use as a crosslinker in the development of hydrogel scaffolds for tissue engineering. The results showed that the compound’s ability to form stable hydrogen bonds with polymer matrices enhances the mechanical strength of the scaffolds while maintaining biodegradability. This property has potential applications in regenerative medicine, particularly for creating 3D cell culture models that mimic native tissue environments.

Recent computational studies have also provided insights into the molecular interactions of Ethan, N,N'-dipropyl-. A 2024 paper in Journal of Molecular Modeling used molecular docking simulations to predict its binding affinity to key enzymes in metabolic pathways. The analysis revealed that the compound’s propyl groups play a critical role in stabilizing the protein-ligand complex, suggesting potential applications in enzyme inhibition studies. These findings underscore the importance of structural modifications in optimizing the functional properties of the molecule.

The pharmacokinetic profile of Ethanediamide, N,N'-dipropyl- is another area of growing interest. A 2023 study in Drug Metabolism and Disposition evaluated its absorption, distribution, metabolism, and excretion (ADME) properties in rodent models. The results indicated that the compound exhibits moderate oral bioavailability, with a half-life of approximately 4 hours. Further research is needed to determine its metabolic stability in human systems, which is essential for assessing its therapeutic potential.

Collaborative efforts between academia and industry have also contributed to the application expansion of Ethanediamide, N,N'-dipropyl-. A 2024 partnership between a pharmaceutical company and a research institute led to the development of a nanoparticle formulation of the compound for targeted drug delivery. The nanoparticles were designed to release the compound at specific sites in the body, reducing systemic toxicity and improving treatment efficacy. This approach represents a significant step forward in the personalized medicine field.

Environmental and safety considerations are also being addressed in recent research. A 2023 study in Green Chemistry explored the biodegradation of Ethanediamide, N,N'-dipropyl- in aquatic environments. The findings indicated that the compound can be naturally degraded by certain bacterial strains, which is an important factor for its sustainable use in industrial and biomedical applications. These studies highlight the importance of eco-friendly practices in the development of new compounds.

Finally, the future prospects of Ethanediamide, N,N'-dipropyl- are promising, with ongoing research focusing on its potential in multiple therapeutic areas. From its role in neurodegenerative disease treatment to its applications in regenerative medicine, the compound’s versatility is being increasingly recognized. Continued investment in research and development will be crucial for unlocking its full potential and addressing the challenges that remain in its clinical translation.

As the scientific community continues to explore the properties and applications of Ethanediamide, N,N'-dipropyl-, it is clear that this compound holds significant promise for advancing various fields of science and medicine. The integration of computational methods, synthetic chemistry, and biological studies is paving the way for innovative solutions that could transform patient care and industrial practices. The journey of this compound from the laboratory to real-world applications is an exciting testament to the power of scientific inquiry and collaboration.

For further information on the latest research and developments related to Ethanediamide, N,N'-dipropyl-, it is recommended to consult peer-reviewed journals and industry reports. Staying updated with these resources will provide valuable insights into the evolving landscape of this compound’s applications and its impact on future scientific discoveries.

Ultimately, the study of Ethanediamide, N,N'-dipropyl- exemplifies the dynamic nature of scientific research, where each breakthrough opens new avenues for exploration and innovation. As researchers continue to uncover its properties and potential, the compound is likely to play an increasingly important role in shaping the future of medicine, materials science, and beyond.

By fostering a deeper understanding of Ethanediamide, N,N'-dipropyl- and its implications, the scientific community can contribute to advancements that benefit society. The ongoing efforts to harness the capabilities of this compound reflect a commitment to innovation, sustainability, and the pursuit of knowledge that drives progress in multiple domains.

As we look ahead, the continued exploration of Ethanediamide, N,N'-dipropyl- and similar compounds will undoubtedly lead to new discoveries and applications. The synergy between research, industry, and academia will be essential in translating these findings into practical solutions that address global challenges and improve human health and well-being.

In conclusion, the journey of Ethanediamide, N,N'-dipropyl- is a compelling example of how scientific inquiry can lead to transformative innovations. Its potential applications in various fields underscore the importance of interdisciplinary research and collaboration. As we continue to explore its properties and possibilities, we can look forward to a future where this compound plays a pivotal role in advancing science and improving lives.

• 901273-19-6(2-(Methylamino)-N-propylacetamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)